Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Election of New Director

On June 10, 2021, at the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of The Beauty Health Company (the "Company"), the Board increased its size from seven to eight directors and appointed Ms. Desiree Gruber to the Board as a Class I Director, effective as of June 11, 2021, to serve until the Company's 2022 Annual Meeting of Stockholders and until her successor is duly elected and qualified. In addition, the Nominating and Corporate Governance Committee of the Board recommended and the Board determined that Ms. Gruber be appointed to the Compensation Committee of the Board, also effective June 11, 2021.

The Nominating and Corporate Governance Committee and the Board determined that Ms. Gruber is independent. There are no transactions between Ms. Gruber and the Company that would be reportable under Item 404(a) of Regulation S-K. Ms. Gruber's compensation will be consistent with the Company's previously disclosed standard compensatory arrangements for non-employee directors, which are described in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission ("SEC") on May 10, 2021, under the heading "Director Compensation." Ms. Gruber's compensation will be prorated to reflect the commencement date of her Board service. Ms. Gruber has entered into the Company's standard form of indemnification agreement, a form of which was filed as Exhibit 10.13 to the Company's Current Report on Form 8-K filed with the SEC on May 10, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses